Ian Shakil - Mar 28, 2024 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF STRATEGY OFFICER, Director
Signature
/s/ Todd Holvick, Attorney-in-Fact
Stock symbol
AUGX
Transactions as of
Mar 28, 2024
Transactions value $
-$129,851
Form type
4
Date filed
4/1/2024, 08:28 PM
Previous filing
Feb 27, 2024
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Sale -$130K -32K -14.57% $4.06 188K Mar 28, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades ranging from $3.9400 to $4.9399. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.